XNASAMED
Market cap2.79bUSD
Dec 24, Last price
85.15USD
1D
0.09%
1Q
-12.39%
Jan 2017
99.74%
Name
Amedisys Inc
Chart & Performance
Profile
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,236,382 0.59% | 2,223,199 0.41% | 2,214,112 6.88% | |||||||
Cost of revenue | 2,025,569 | 2,017,483 | 1,944,596 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 210,813 | 205,716 | 269,516 | |||||||
NOPBT Margin | 9.43% | 9.25% | 12.17% | |||||||
Operating Taxes | 50,559 | 42,545 | 70,065 | |||||||
Tax Rate | 23.98% | 20.68% | 26.00% | |||||||
NOPAT | 160,254 | 163,171 | 199,451 | |||||||
Net income | (9,747) -108.22% | 118,609 -43.27% | 209,072 13.87% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (6,529) | 2,278,668 | 3,851,224 | |||||||
BB yield | 0.21% | -83.53% | -72.15% | |||||||
Debt | ||||||||||
Debt current | 88,886 | 49,017 | 44,228 | |||||||
Long-term debt | 498,550 | 591,949 | 601,926 | |||||||
Deferred revenue | 15,100 | |||||||||
Other long-term liabilities | 16,518 | 4,808 | 4,979 | |||||||
Net debt | 394,886 | 539,926 | 550,360 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 137,188 | 133,283 | 188,893 | |||||||
CAPEX | (5,620) | (7,215) | (6,721) | |||||||
Cash from investing activities | 35,064 | (94,486) | (281,607) | |||||||
Cash from financing activities | (87,522) | (30,433) | 55,126 | |||||||
FCF | 190,261 | 122,072 | 143,107 | |||||||
Balance | ||||||||||
Cash | 126,450 | 40,540 | 42,694 | |||||||
Long term investments | 66,100 | 60,500 | 53,100 | |||||||
Excess cash | 80,731 | |||||||||
Stockholders' equity | 801,232 | 812,710 | 684,073 | |||||||
Invested Capital | 1,553,969 | 1,649,322 | 1,526,914 | |||||||
ROIC | 10.01% | 10.27% | 15.05% | |||||||
ROCE | 12.58% | 12.32% | 17.65% | |||||||
EV | ||||||||||
Common stock shares outstanding | 32,599 | 32,653 | 32,972 | |||||||
Price | 95.06 13.79% | 83.54 -48.39% | 161.88 -44.81% | |||||||
Market cap | 3,098,861 13.60% | 2,727,832 -48.89% | 5,337,507 -45.30% | |||||||
EV | 3,547,016 | 3,322,758 | 5,932,839 | |||||||
EBITDA | 268,656 | 276,680 | 340,781 | |||||||
EV/EBITDA | 13.20 | 12.01 | 17.41 | |||||||
Interest | 31,274 | 22,228 | 9,525 | |||||||
Interest/NOPBT | 14.83% | 10.81% | 3.53% |